Maitani T, Waalkes M P, Klaassen C D
Toxicol Appl Pharmacol. 1984 Jun 30;74(2):237-43. doi: 10.1016/0041-008x(84)90148-0.
Distribution of Cd was compared after oral administration of either Cd ions or Cd-thionein (Cd-TH). Mice received 0.5 mg Cd/kg, po as CdCl2 in saline, CdCl2 in control rat liver homogenate, Cd-TH in saline, Cd-TH in liver homogenate, or liver homogenate from Cd-treated rats. In all cases, 85-90% of the Cd dose was present in feces within 24 hr. However, in groups receiving CdCl2, more Cd was found in feces on Days 2 and 3 in comparison to those receiving Cd-TH. All treatments resulted in lower levels of Cd in liver than in kidney. In addition, tissue levels indicate that less Cd was absorbed when rats received Cd-TH in saline than CdCl2 in saline. Cd-TH added to liver homogenate or liver homogenate containing Cd-TH increased the absorption of Cd resulting in renal Cd levels similar to those in mice receiving CdCl2 in saline. The kidney/liver Cd concentration ratio (9) was the same for Cd-TH in all three media. Although Cd-TH gave much higher kidney/liver Cd ratios than CdCl2 (9 vs 2), renal Cd concentrations were the same or lower than after CdCl2 treatments. Results indicate that the high kidney/liver Cd ratio after Cd-TH treatment versus CdCl2 is due to lower concentrations of Cd in liver rather than marked increases in renal Cd levels. Heating of Cd-TH did not result in lower amounts of Cd in kidney. While the chemical form of Cd administered affects the absorption and distribution of Cd, the amount of Cd reaching the kidney after Cd-TH administration is similar to that after CdCl2 administration.
在口服镉离子或镉硫蛋白(Cd-TH)后,对镉的分布情况进行了比较。小鼠经口给予0.5 mg Cd/kg,分别以氯化镉溶于生理盐水、氯化镉溶于对照大鼠肝脏匀浆、镉硫蛋白溶于生理盐水、镉硫蛋白溶于肝脏匀浆,或来自镉处理大鼠的肝脏匀浆的形式给药。在所有情况下,24小时内85 - 90%的镉剂量存在于粪便中。然而,与接受镉硫蛋白的组相比,接受氯化镉的组在第2天和第3天粪便中发现的镉更多。所有处理组肝脏中的镉水平均低于肾脏。此外,组织水平表明,当大鼠接受溶于生理盐水的镉硫蛋白时,吸收的镉比接受溶于生理盐水的氯化镉时少。添加到肝脏匀浆中的镉硫蛋白或含有镉硫蛋白的肝脏匀浆会增加镉的吸收,导致肾脏镉水平与接受溶于生理盐水的氯化镉的小鼠相似。在所有三种介质中,镉硫蛋白的肾/肝镉浓度比(9)相同。尽管镉硫蛋白的肾/肝镉比远高于氯化镉(9比2),但肾脏镉浓度与氯化镉处理后相同或更低。结果表明,与氯化镉相比,镉硫蛋白处理后肾/肝镉比高是由于肝脏中镉浓度较低,而非肾脏镉水平显著升高。加热镉硫蛋白并未导致肾脏中镉含量降低。虽然所给镉的化学形式会影响镉的吸收和分布,但镉硫蛋白给药后到达肾脏的镉量与氯化镉给药后相似。